St.Jude Medical has announced CE Mark approval for magnetic resonance (MR) conditional labeling for the company�s Quadra Allure MP cardiac...
The FDA has announced approval of Iperia ProMRI HF-T, a cardiac resynchronization defibrillator, from Biotronik, that provides heart failure patients...
Medtronic has received U.S. FDA approval for the Claria MRI Quad Cardiac Resynchronization Therapy Defibrillator (CRT-D) SureScan device for patients...
Medtronic plc is the first company to receive FDA approval for its suite of cardiac rhythm and heart failure devices...
The last pacing guidelines of the European Society of Cardiology (ESC) were published in 2013; therefore, a new set of guidelines was felt to be timely and necessary.
Boston Scientific has received FDA approval for the EMBLEM MRI Subcutaneous Implantable Defibrillator (S-ICD) System, as well as magnetic resonance...
Aims: To assess the ability of cardiovascular magnetic resonance (CMR) to (i) measure changes in response to chemotherapy; (ii) assess the correlation between haematological response and changes in extracellular volume (ECV); and (iii) assess the association between changes in ECV and prognosis over and above existing predictors.
Boston Scientific has launched the Resonate family of implantable cardioverter defibrillator (ICD) and cardiac resynchronization therapy defibrillator (CRT-D) systems featuring...
Urologists face a dilemma when a lesion identified on multiparametric magnetic resonance imaging is benign on image guided fusion biopsy.
Bayer announced the FDA has approved Gadavist (gadobutrol) injection for use in cardiac magnetic resonance (MR) imaging to assess myocardial...